Procyrion CEO and leadership

Experienced start-up entrepreneur with a focus on medical devices, diagnostics and healthcare services. Managing Director of AlphaDev LLC; Vice President of BCM Technologies; McKinsey & Co. (Member of Pharmaceutical and Medical Products Practice); Ph.D. from Brown University’s Artificial Organs, Biomaterials, and Cellular Technology program; Previous corporate Board seats include Medical Metrics, Fairway Medical Technologies, Spectral Genomics (acquired by Perkin Elmer) and Kardia Therapeutics (founding president).

Practicing cardiologist and leader in the field of heart failure. Medical Director, Mechanical Support Devices in Heart Failure, Texas Heart Institute; Advisory Board, Boston Scientific (LATITUDE HF monitoring system); Author on two NEJM articles that led to the FDA approval of the Heartmate II™ LVAD; Principal Investigator on ORQIS MOMENTUM Trial; Basic Science Researcher in Heart Failure, THI, Baylor College of Medicine and UT Houston Medical School; Co-founder and President, Houston Heart Failure Society, long-standing research collaborator with NASA Johnson Space Center’s human space flight physiology laboratory.

Experienced venture-backed founder of three start-ups; McKinsey & Co. consultant with CV OR and cath-lab focused engagements; Ph.D. from Oxford University in Sensors, Sensor Fusion, Control Systems, and Artificial Vision.

Practicing cardiologist and leader in the field of heart failure. Medical Director, Mechanical Support Devices in Heart Failure, Texas Heart Institute; Advisory Board, Boston Scientific (LATITUDE HF monitoring system); Author on two NEJM articles that led to the FDA approval of the Heartmate II™ LVAD; Principal Investigator on ORQIS MOMENTUM Trial; Basic Science Researcher in Heart Failure, THI, Baylor College of Medicine and UT Houston Medical School; Co-founder and President, Houston Heart Failure Society, long-standing research collaborator with NASA Johnson Space Center’s human space flight physiology laboratory.